Pompe Disease Market Global Trends and Forecasts to 2030

Increasing prevalence of Pompe Disease is one of the key factors driving Pompe Disease market revenue growth

The global Pompe Disease market size reached USD 1,386.09 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to a latest analysis by Emergen Research. Increasing prevalence of Pompe Disease, rising number of clinical studies and trials in the field of Pompe-disease-based treatments, and introduction of novel and advanced screening platforms for early diagnosis are crucial factors driving market revenue growth.

Pompe disease is a hereditary, frequently fatal ailment that affects the heart and skeletal muscles. It is thought to affect one in every 40,000 births, according to the National Institute of Neurological Disorders and Stroke. Mutations in a gene that produces an enzyme called acid alpha-glucosidase cause it (GAA). Many researchers are trying to bet­ter understand the earliest features and manifestations of late-onset Pompe disease novel screening platforms such as newborn screening.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/1081

According to the Muscular Dystrophy Association (MDA), 20 states are now testit newborns through newborn screening platforms for Pompe Disease, the latest neuromuscular disease, which is being added to a list of significant genetic disorders for which children can be tested shortly after delivery in the United States. We are investi­gating if starting people early on the right dose of ERT could impact outcomes. Targeted screening of at-risk individuals, as well as general newborn screening, can lead to early detection and treatment of Pompe disease patients, potentially improving clinical outcomes. Other advanced and creative diagnostic systems, such as enzyme activity assessment using a tandem-mass-spectrometry-based assay for Pompe disease, are being produced, examined, and validated in large screening programs.

Global Pompe Disease Market Research Report and Forecast to 2030 is an investigative report providing an extensive study of the global Pompe Disease Market with regards to market size, market share, current and emerging trends, and latest technological developments. The report also sheds light on the competitive landscape of the Pompe Disease Market on the global and regional scale, along with a thorough forecast estimation to 2020. The new report is updated with the impact of the COVID-19 pandemic on the Pompe Disease Market. It analyzes the impact of the pandemic with regards to economic landscape and government regulations in each region.

To know more about the report @ https://www.emergenresearch.com/industry-report/pompe-disease-market

Emergen Research has segmented global Pompe Disease market on the basis of type, treatment type, end-use and region:

Type Outlook (Revenue, USD Million; 2019-2030)

Infantile-Onset Pompe Disease (IOPD)

Late-Onset Pompe Disease (LOPD)

Treatment Type Outlook (Revenue, USD Million; 2019-2030)

Enzyme Replacement Therapy (ERT)

Chaperone Therapy

Substrate Replacement Therapy (SRT)

Others

End-Use Outlook (Revenue, USD Million; 2019-2030)

Hospitals

Diagnostic Centers

Others

The report further studies the key companies operating in the industry and their company profiles, product portfolio, expansion strategies, and strategic alliances such as mergers and acquisitions, collaborations, and joint ventures, among others. It also offers insights into their market reach and global position, along with highlights about their achievements and financial standings.

Key players include

Sanofi S.A.,

Amicus Therapeutics, Inc.,

BioMarin Pharmaceutical,

Valerion Therapeutics,

Oxyrane,

Genzyme Corporation,

EpiVax, Inc.,

Bayer AG,

Audentes Therapeutics, and

Sangamo Therapeutics

Request a discount on the report @ https://www.emergenresearch.com/request-discount/1081

Regional Segmentation

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The report addresses the following key points:

The report estimates the expected market size from 2022-2030

The report provides a forecast of market drivers, restraints, and future opportunities for the Pompe Disease market

The report further analyses the changing market dynamics

Regional analysis and segmentation of the market with analysis of the regions and segments expected to dominate the market growth

Extensive competitive landscape mapping with profiles of the key competitors

In-depth analysis of business strategies and collaborations such as mergers and acquisitions adopted by the key companies

Revenue forecast, country scope, application insights, and product insights

Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/1081

Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.

Take a Look at our other Reports:

In-Situ Hybridization Market

https://www.biospace.com/article/in-situ-hybridization-market-size-to-reach-usd-1-556-6-million-in-2028-growing-at-a-cagr-of-7-1-percent-according-to-emergen-research/

Interventional Cardiology Devices Market

https://www.biospace.com/article/interventional-cardiology-devices-market-size-to-reach-usd-26-84-billion-in-2028-growing-at-a-cagr-of-8-7-percent-according-to-emergen-research/

Laboratory Centrifuges Market

https://www.biospace.com/article/laboratory-centrifuges-market-size-to-reach-usd-1-45-billion-in-2028-growing-at-a-cagr-of-2-6-percent-according-to-emergen-research/

Nanotechnology Market

https://www.biospace.com/article/nanotechnology-market-size-to-reach-usd-290-93-billion-in-2028-growing-at-a-cagr-of-18-3-percent-according-to-emergen-research/

Near-Infrared Imaging Market

https://www.biospace.com/article/near-infrared-imaging-market-size-to-reach-usd-1535-0-million-in-2028-growing-at-a-cagr-of-13-2-percent-according-to-emergen-research/

Orthopedic Biomaterial Market

https://www.biospace.com/article/orthopedic-biomaterial-market-size-to-reach-usd-29-62-billion-in-2028-growing-at-a-cagr-of-9-4-percent-according-to-emergen-research/

RNA Transcriptomics Market

https://www.biospace.com/article/rna-transcriptomics-market-size-to-reach-usd-12-46-billion-in-2028-growing-at-a-cagr-of-13-6-percent-according-to-emergen-research/

About Us:

At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release @ https://www.emergenresearch.com/press-release/global-pompe-disease-market 


Jannashar

80 Blog posts

Comments